ストックスクリーナーアプリを入手
5.97
3.29%
0.19
アフターアワーズ：
5.97
前日終値:
$5.78
開ける：
$5.84
24時間の取引高:
677.64K
Relative Volume:
1.01
時価総額：
$655.16M
収益：
$58.49M
当期純損益:
$-105.04M
株価収益率:
-4.5934
EPS:
-1.2997
ネットキャッシュフロー:
$-13.78M
1週間 パフォーマンス:
+10.76%
1か月 パフォーマンス:
+30.07%
6か月 パフォーマンス:
-23.95%
1年 パフォーマンス:
-55.74%
1日の値動き範囲:
$5.84
$6.23
1週間の範囲:
$5.46
$6.33
52週間の値動き範囲:
$3.30
$13.70
Immatics N V Stock (IMTX) Company Profile
IMTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
5.97 | 655.16M | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-28 | 開始されました | Deutsche Bank | Buy |
| 2024-10-07 | 開始されました | Piper Sandler | Overweight |
| 2023-11-02 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-03-31 | 開始されました | Mizuho | Buy |
| 2023-03-24 | 開始されました | Bryan Garnier | Buy |
| 2020-11-20 | 開始されました | BofA Securities | Buy |
| 2020-09-22 | 開始されました | Goldman | Buy |
| 2020-07-27 | 開始されました | SVB Leerink | Outperform |
| 2020-07-24 | 開始されました | Jefferies | Buy |
すべてを表示
Immatics N V (IMTX) 最新ニュース
Immatics Announces Third Quarter 2024 Financial Results, Business Update and First Clinical Data on TCER® IMA402 Targeting PRAME - Revista ADVFN
Immatics rises on data from early stage cell therapy trial - MSN
Millennium Management LLC Has $1.11 Million Holdings in Immatics (NASDAQ:IMTX) - Defense World
Immatics: Taking Off On A PRAME Rocketship - Seeking Alpha
Does Immatics (IMTX) Have the Potential to Rally 174.54% as Wall Street Analysts Expect? - Yahoo Finance
Immatics Announces Annual General Meeting for June 2025 - TipRanks
immatics n.v. announces upcoming annual general meeting By Investing.com - Investing.com South Africa
immatics n.v. announces upcoming annual general meeting - Investing.com
Immatics (IMTX) Soars After Positive Trial Results for Cell Ther - GuruFocus
Cantor Fitzgerald reiterates overweight rating on Immatics stock By Investing.com - Investing.com UK
Immatics Presents Promising IMA203 Data at ASCO 2025 - TipRanks
Form 6-K Immatics N.V. For: Jun 02 - StreetInsider
Northern Trust Corp Purchases 11,304 Shares of Immatics (NASDAQ:IMTX) - Defense World
Immatics (IMTX) Shares Promising Data from IMA203 Melanoma Trials | IMTX Stock News - GuruFocus
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 - GlobeNewswire
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO - GuruFocus
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma | IMTX Stock News - GuruFocus
Immatics N.V. Reports Promising Long-Term Efficacy and Safety Data from Phase 1b Trial of IMA203 PRAME Cell Therapy in Metastatic Melanoma - Nasdaq
Immatics IMA203 PRAME Cell Therapy Data Presented at 2025 ASCO Annual Meeting Continues to Show Strong Anti-tumor Activity and Durability in Patients with Metastatic Melanoma - Yahoo
Immatics (NASDAQ:IMTX) Receives $17.00 Average Price Target from Analysts - Defense World
Immatics N.V. (IMTX) Stock Analysis: Uncovering a 163% Upside Potential in the Biotech Arena - DirectorsTalk Interviews
Long Term Trading Analysis for (IMTX) - news.stocktradersdaily.com
Immatics (NASDAQ:IMTX) Coverage Initiated by Analysts at Deutsche Bank Aktiengesellschaft - Defense World
D. E. Shaw & Co. Inc. Has $176,000 Stake in Immatics (NASDAQ:IMTX) - Defense World
Deutsche Bank Initiates Coverage of Immatics N.V. (IMTX) with Buy Recommendation - Nasdaq
Immatics (IMTX) Receives "Buy" Rating from Deutsche Bank | IMTX Stock News - GuruFocus
Deutsche Bank Initiates Coverage on Immatics With Buy Rating, $10 Price Target - marketscreener.com
Deutsche Bank Gives Immatics (IMTX) a Boost with Buy Rating and $10 Target | IMTX Stock News - GuruFocus
Deutsche Bank sets $10 target for Immatics stock on Buy rating - Investing.com UK
Immatics FY2025 EPS Forecast Increased by Cantor Fitzgerald - Defense World
Lacklustre Performance Is Driving Immatics N.V.'s (NASDAQ:IMTX) Low P/S - simplywall.st
The Manufacturers Life Insurance Company Sells 71,487 Shares of Immatics (NASDAQ:IMTX) - Defense World
We're Hopeful That Immatics (NASDAQ:IMTX) Will Use Its Cash Wisely - Yahoo Finance
Immatics: Q1 Earnings Snapshot - CT Insider
Immatics Announces First Quarter 2025 Financial Results and Business Update - GlobeNewswire
Immatics NV earnings missed by €0.07, revenue topped estimates - Investing.com South Africa
Immatics NV reports results for the quarter ended March 31Earnings Summary - TradingView
IMTX Sees Revenue Decline, Highlights Advances in Melanoma Thera - GuruFocus
Immatics Reports Increased Q1 2025 Loss Amid Rising R&D Costs - TipRanks
Immatics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Immatics (IMTX) Projected to Post Quarterly Earnings on Tuesday - Defense World
IMTXImmatics N.V Latest Stock News & Market Updates - Stock Titan
(IMTX) Proactive Strategies - news.stocktradersdaily.com
Immatics US opens 100,000-square-foot Stafford cell-therapy manufacturing plant (PHOTOS) - The Business Journals
Guggenheim Capital LLC Takes $101,000 Position in Immatics (NASDAQ:IMTX) - Defense World
Immatics (NASDAQ:IMTX) Shares Sold by JPMorgan Chase & Co. - Defense World
Are Immatics N.V (IMTX) shares a good deal now? - uspostnews.com
Immatics Announces Upcoming Oral and Poster Presentation on IMA2 - GuruFocus
Immatics N V (IMTX) 財務データ
収益
当期純利益
現金流量
EPS
1.21%
1.51%
大文字化:
|
ボリューム (24 時間):